MITF-Driven Plasticity in Melanoma: Key to Overcoming Therapy Resistance
MITF-dependent phenotype switching is identified as a central mechanism enabling melanoma cells to escape therapy.
Indication
Clinical and regulatory intelligence for Melanoma with 7 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.